| Acrp30 | Adipocyte complement related protein of 30 kDa |
| apM1 | Adipose most abundant gene transcript1 |
| GBP28 | Gelatin-binding protein of 28 kDa |
| AdipoR1 | Adiponectin receptor 1 |
| AdipoR2 | Adiponectin receptor 2 |
| PPARγ | Peroxisome proliferator-activated receptor gamma |
| TZD | Thiazolidinedione |
| PPRE | PPAR response element |
| HMW adiponectin | High molecular weight adiponectin |
| FoxO1 | Forkhead box protein O1 |
| Sirt1 | Sirtuin 1 |
| C/EBPα | CCAAT-enhancer-binding proteins |
| SERBP | Sterol regulatory element-binding proteins |
| SRE | SERBP response element |
| CREB | cAMP response element-binding protein |
| ATF3 | Activating transcription factor 3 |
| NFAT | Nuclear factor of activated T-cells |
| AP-2β | Activating enhancer binding protein-2β |
| IGFBP-3 | IGF-1-binding protein 3 |
| Id3 | Inhibitor of differentiation-3 |
| HIF1α | Hypoxia inducible factor alpha |
| TNFα | Tumor necrosis factor alpha |
| IFNγ | Interferon gamma |
| IL | Interleukin |
| JNK | c-Jun N-terminal kinases |
| ERK | Extracellular-signal-regulated kinase |
| MAPK | Mitogen-activated protein kinases |
| ERp44 | ER chaperone protein 44 |
| Ero-1La | ERO1-like protein alpha |
| DsbA-L | Disulfide-bond A oxidoreductase-like protein |
| COX2 | Cyclooxygenase 2 |
| VEGF | Vascular endothelial growth factor |
| PGES | Prostaglandin E synthase |
| hCG | Human chorionic gonadotropin |
| AMPK | AMP activated protein kinase |
| PCOS | Polycystic ovary syndrome |
| SNP | Single nucleotide polymorphism |
| GLUT4 | Glucose transporter type 4 |
| CNS | Central nervous system |
| GH | Growth hormone |
| LH | Luteinizing hormone |
| eNOS | Endothelial NOS |
| NFκB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| MMP | Matrix metalloproteinase |
| CVD | Cardiovascular disease |
| EP4 | Prostaglandin E2 receptor 4 |
| SphK | Sphingosine kinase |
| VCAM-1 | Vascular cell adhesion protein 1 |
| BMI | Body mass index |
| LDL | Low density lipoprotein |
| HDL | High density lipoprotein |
| apoA-I | Apolipoprotein A-I |
| NO | Nitric oxide |
| PI3K | Phosphoinositide 3-kinase |
| PDGF | Platelet-derived growth factor |
| HB-EGF | Heparin-binding epidermal growth factor |
| BFGF | Basic fibroblast growth factor |
| EGF | Epidermal growth factor |
| OSAS | Obstructive sleep apnea syndrome |
| T2DM | Type 2 diabetes mellitus |
| IARC | International agency for research on cancer |
| WCRF | World cancer research fund |
| SMD | Standard mean differences |
| RIA | Radioimmunoassay |
| ELISA | Enzyme linked immunosorbent assay |
| HGF | Hepatocyte growth factor |
| bFGF | Basic fibroblast growth factor |
| FGF-2 | Fibroblast growth factor-2 |
| HUVEC | Human Umbilical Vein Endothelial Cells |
| mTOR | Mammalian target of rapamycin |
| ROS | Reactive oxygen species |
| Trx | Thioredoxin |
| CRC | Colorectal cancer |
| PTP1B | Protein tyrosine phosphatase 1B |
| NSCLC | Non-small cell lung carcinoma |
| EMT | Epithelial to mesenchymal transition |
| PKA | Protein kinase A |
| IGF1 | Insulin like growth factor-1 |
| COPD | Chronic Obstructive Pulmonary Disease |
| STAT3 | Signal transducer and activator of transcription 3 |
| GSK3β | Glycogen synthase kinase 3 beta |
| DsbA-L | Disulfide-bond A oxidoreductase-like protein |